Novartis Investigative Site

Kongsvinger 2212

0 studies enrolling now · 2 studies all time

What they study most

Non-radiographic Spondyloarthritis, Spondylitis, Ankylosing

Studies at this site

• Study of Efficacy and Safety of Secukinumab in Patients With Non-radiographic Axial Spondyloarthritis — Completed
• 16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis — Completed